{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:27:01Z","timestamp":1793935621558,"version":"4.8.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. The present study aims to compare the forkhead box E1 (FOXE1), insulin-like growth factor II mRNA binding protein 3 (IMP-3), and telomerase reverse transcriptase (TERT) immunoexpressions with clinical and prognostic histopathological findings in patients with papillary thyroid carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The study included 166 patients diagnosed with PTC. FOXE1, IMP-3, and TERT antibodies were applied to the sections, and the results were compared with patient characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The results revealed a significant relationship between FOXE1 positivity and the presence of lymphovascular invasion. There was also a significant relationship between TERT positivity and the absence of lymphocytic thyroiditis in the non-tumor thyroid tissue. No statistically significant relationship was observed between antibody staining patterns and the other studied parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In conclusion, FOXE1 immunoreactivity may be a sign of lymphovascular invasion in PTCs that are prone to local extension through lymphatic vessels or direct local invasion. The patients with FOXE1 positivity require close attention with regards to lymphovascular invasion and lymph node metastasis. The authors consider that prospective studies on larger series involving molecular analysis of fine-needle aspiration specimens would contribute to preoperative diagnosis and clinical management of the patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpm.ijpm_909_24","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:00:22Z","timestamp":1790658022000},"page":"405-412","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["FOXE1, IMP-3, and TERT expressions in papillary thyroid carcinomas"],"prefix":"10.4103","volume":"69","author":[{"given":"Nurtac","family":"Sarikas","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Kastamonu University, Kastamonu, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuray","family":"Can","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necdet","family":"Sut","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz A.","family":"Sezer","sequence":"additional","affiliation":[{"name":"Independent Researcher, Division of Endocrinology and Metabolism, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket Y.","family":"Bulbul","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Tastekin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Usta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulya Oz","family":"Puyan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin D.","family":"Yalta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Ustun","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"R1-20261106","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R2-20261106","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jso.20700","article-title":"Pathology and genetics of thyroid carcinoma","volume":"94","author":"DeLellis","year":"2006","journal-title":"J Surg Oncol"},{"issue":"(Suppl 2)","key":"R3-20261106","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/modpathol.2010.167","article-title":"Molecular analysis of thyroid tumors","volume":"24","author":"Nikiforov","year":"2011","journal-title":"Mod Pathol"},{"key":"R5-20261106","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1006\/geno.1997.4692","article-title":"FKHL15, a new human member of the forkhead gene family located on chromosome 9q22","volume":"41","author":"Chadwick","year":"1997","journal-title":"Genomics"},{"key":"R6-20261106","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1093\/emboj\/16.11.3185","article-title":"TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation","volume":"16","author":"Zannini","year":"1997","journal-title":"EMBO J"},{"key":"R7-20261106","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/thy.2012.0466","article-title":"Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry","volume":"23","author":"Bychkov","year":"2013","journal-title":"Thyroid"},{"key":"R8-20261106","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1066896914554832","article-title":"Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma","volume":"23","author":"Yorukoglu","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"R9-20261106","first-page":"37","article-title":"Role of TERT gene mutation in the pathogenesis of anaplastic thyroid carcinoma","volume":"22","author":"Alhejaily","year":"2025","journal-title":"Mol Clin Oncol"},{"key":"R10-20261106","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.21037\/atm-20-5024","article-title":"Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: Implications in precision oncology-A narrative review","volume":"8","author":"Yuan","year":"2020","journal-title":"Ann Transl Med"},{"key":"R11-20261106","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"R12-20261106","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20261106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrg2523","article-title":"The evolution of Fox genes and their role in development and disease","volume":"10","author":"Hannenhalli","year":"2009","journal-title":"Nat Rev Genet"},{"key":"R14-20261106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3892\/mmr.2013.1494","article-title":"Expression and clinical significance of FOXE1 in papillary thyroid carcinoma","volume":"8","author":"Fan","year":"2013","journal-title":"Mol Med Rep"},{"key":"R15-20261106","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/ERC-19-0156","article-title":"FOXE1 regulates migration and invasion in thyroid cancer cells and targets ZEB1","volume":"27","author":"Morillo-Bernal","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"R16-20261106","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/thy.2013.0274","article-title":"FOXE1 association with differentiated thyroid cancer and its progression","volume":"24","author":"Penna-Martinez","year":"2014","journal-title":"Thyroid"},{"key":"R17-20261106","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.0022-202X.2004.22505.x","article-title":"FOXE1, a new transcriptional target of GLI2, is expressed in human epidermis and basal cell carcinoma","volume":"122","author":"Eichberger","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R18-20261106","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng.339","article-title":"Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations","volume":"41","author":"Gudmundsson","year":"2009","journal-title":"Nat Genet"},{"key":"R19-20261106","doi-asserted-by":"crossref","first-page":"e1000637","DOI":"10.1371\/journal.pgen.1000637","article-title":"The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1\/USF2 transcription factors","volume":"5","author":"Landa","year":"2009","journal-title":"PLoS Genet"},{"key":"R20-20261106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12022-009-9079-x","article-title":"Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors","volume":"20","author":"Slosar","year":"2009","journal-title":"Endocr Pathol"},{"key":"R21-20261106","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/modpathol.2010.117","article-title":"Poorly differentiated carcinoma of the thyroid: Validation of the Turin proposal and analysis of IMP3 expression","volume":"23","author":"Asioli","year":"2010","journal-title":"Mod Pathol"},{"key":"R22-20261106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PDM.0b013e3181b6a528","article-title":"Diagnostic utility of IMP3 expression in thyroid neoplasms: A quantitative RT-PCR study","volume":"19","author":"Jin","year":"2010","journal-title":"Diagn Mol Pathol"},{"key":"R23-20261106","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s002680010174","article-title":"Growth regulation of thyroid and thyroid tumors in humans","volume":"24","author":"Goretzki","year":"2000","journal-title":"World J Surg"},{"key":"R24-20261106","doi-asserted-by":"crossref","first-page":"E914","DOI":"10.1210\/jc.2012-3396","article-title":"RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers","volume":"98","author":"Gupta","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20261106","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R26-20261106","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"R27-20261106","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12022-015-9382-7","article-title":"Histopathological evidence of lymph node metastasis in papillary thyroid carcinoma","volume":"26","author":"Can","year":"2015","journal-title":"Endocr Pathol"},{"key":"R28-20261106","doi-asserted-by":"crossref","first-page":"85948","DOI":"10.18632\/oncotarget.13288","article-title":"Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT","volume":"7","author":"Bullock","year":"2016","journal-title":"Oncotarget"},{"key":"R29-20261106","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14744\/SEMB.2025.67864","article-title":"What has changed in the 2025 american thyroid association management guidelines for adult patients with differentiated thyroid cancer? Part 3: Long-Term surveillance, advanced and novel treatments","volume":"59","author":"Uludag","year":"2025","journal-title":"Med Bull Sisli Etfal Hosp"},{"key":"R30-20261106","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_909_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:00:58Z","timestamp":1793934058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_909_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_909_24","relation":{},"ISSN":["0377-4929","0974-5130"],"issn-type":[{"value":"0377-4929","type":"print"},{"value":"0974-5130","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2024-11-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}